Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Glioma × Escitalopram × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Depression 3 Polycystic Ovary Syndrome 2 Neoplasms 2 Depressive Disorder, Major 2 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Liver Neoplasms 1 Glioma 1 Gallbladder Neoplasms 1 Fatigue 1 Esophageal Neoplasms 1 ENT Cancer 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Neoplasms 1 Bile Duct Neoplasms 1 Behavior, Addictive 1 Asthma 1

Interventions

Temozolomide 132 Bevacizumab 62 Radiotherapy 52 Magnetic Resonance Spectroscopy 51 Irinotecan 25 Carboplatin 22 Surgical Procedures, Operative 18 Radiation 18 Carmustine 18 Specimen Handling 17 Nivolumab 15 Lomustine 15 Biopsy 15 Aminolevulinic Acid 15 pembrolizumab 12 Radiotherapy, Intensity-Modulated 12 trametinib 11 Radiosurgery 11 Cyclophosphamide 10 Topotecan 9 IL13-PE38 9 Everolimus 9 ribociclib 8 fluorodopa F 18 8 dabrafenib 8 X-Rays 8 Imatinib Mesylate 8 Filgrastim 8 Etoposide 8 Erlotinib Hydrochloride 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03728673 2025-06-22

A Study Utilizing Escitalopram in Glioma Patients

University of Nebraska

Phase 2 Recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡